GSK-2194069

• Catalog number
  B1571-5
• Price
  Please ask
• Size
  5 mg

• Alternative_name
  4-[4-(benzofuran-5-yl)phenyl]-3-[[(3S)-1-(cyclopropanecarbonyl)pyrrolidin-3-yl]methyl]-1H-1,2,4-triazol-5-one;2-(hydroxymethyl)-2-(methoxymethyl)quinuclidin-3-one
• Description
  GSK-2194069 is a potent and specific inhibitor of the β-ketoacyl reductase (KR) activity of hFAS (human Fatty Acid Synthase).
• CAS Number
  1332331-21-1
• Structure Available
  Yes
• Molecular Formula
  C₂₅H₂₄N₄O₃
• Molecular Weight
  428.48
• Cell Permeable
  Yes
• Purity
  ≥98% by HPLC
• Solubilities
  DMSO
• Handling
  Protect from air and light
• Tag Line
  A potent human Fatty Acid Synthase (FAS) inhibitor
• Storage Condition
  -20°C
• Shipping Condition
  Gel Pack
• Shelf Life
  36 months
• PubChem CID
  67376285
• PubChem CID Link
• SMILES
  C1CC1C(=O)N2CCC(C2)CC3=NNC(=O)N3C4=CC=C(C=C4)C5=CC6=C(C=C5)OC=C6
• InChi
  InChI=1S/C25H24N4O3/c30-24(18-1-2-18)28-11-9-16(15-28)13-23-26-27-25(31)29(23)21-6-3-17(4-7-
• InChi Key
  AQTPWCUIYUOEMG-INIZCTEOSA-N
• Data Sheet Link
• MSDS Available
  Yes

• Gene target
  GSK-2194069  
• Short name
  GSK-2194069
• Alternative name
  GSK-2194069

Similar products